Your session is about to expire
← Back to Search
Resistance Training During Menstrual Cycle for Women's Health (MCPBT Trial)
N/A
Waitlist Available
Research Sponsored by McMaster University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights
MCPBT Trial Summary
This trial aims to improve understanding of the effect of the menstrual cycle on exercise adaptations, improving women's health info & reducing sex gap in exercise physiology.
Who is the study for?
This trial is for women aged 18-30 with a regular menstrual cycle, BMI of 18-35, and in good health. Participants should not be on hormonal contraceptives or smoke. They must also have exercised less than three times a week for the past six months and cannot be using certain medications.Check my eligibility
What is being tested?
The study tests if resistance training benefits vary across different phases of the menstrual cycle. Women's legs will be assigned to one of four groups: non-exercise control, exercise control, follicular phase training, or luteal phase training.See study design
What are the potential side effects?
Since this trial involves standard resistance exercises without medication or invasive procedures, side effects are minimal but may include typical exercise-related discomfort such as muscle soreness.
MCPBT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Muscle Hypertrophy
Muscular Strength
MCPBT Trial Design
4Treatment groups
Experimental Treatment
Active Control
Group I: Luteal Based Training (LUT)Experimental Treatment1 Intervention
This condition will have high volume of RET (20 weekly sets) during the luteal phase and low volume during the follicular phase of the participant's menstrual cycle.
Group II: Follicular Based Training (FOL)Experimental Treatment1 Intervention
This condition will have high volume of RET (20 weekly sets) during the follicular phase and low volume during the luteal phase of the participant's menstrual cycle.
Group III: Exercise Control (EX)Experimental Treatment1 Intervention
This condition will have consistent training volume (12 weekly sets) throughout the duration of the study, regardless of what phase of the menstrual cycle the participant is in.
Group IV: Non-Exercise Control (CON)Active Control1 Intervention
This condition will serve as a non-exercise control and will not be performing resistance exercise training (RET)
Find a Location
Who is running the clinical trial?
McMaster UniversityLead Sponsor
880 Previous Clinical Trials
2,597,804 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not using any form of hormonal birth control.I or someone in my family has had blood clots.I do not have any health issues like severe diarrhea or swallowing problems.I am currently using hormonal birth control.I have a history of muscle or neuromuscular diseases.I am a woman aged between 18 and 30.I am not taking medications that affect protein metabolism.I am taking blood thinners.I have a history of bleeding disorders or I'm on blood thinning medication.
Research Study Groups:
This trial has the following groups:- Group 1: Exercise Control (EX)
- Group 2: Non-Exercise Control (CON)
- Group 3: Follicular Based Training (FOL)
- Group 4: Luteal Based Training (LUT)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this clinical experiment have an age requirement of at least 18 years?
"This medical trial is accepting individuals over 18 years of age and below the threshold of 30."
Answered by AI
To whom does this experiment offer access?
"All applicants should be between 18 and 30 years old, experience menstruation, and will need to meet the 24 available spots in order to join this trial."
Answered by AI
Is this research endeavor currently accepting new participants?
"According to clinicaltrials.gov, this trial has not been actively seeking patients since June 30th 2023. Nevertheless, there are 8 other medical studies that require enrolment at the present time."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger